Ameriprise’s Precigen PGEN Stock Holding History

Ameriprise’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45,349	Closed	-$48.1K	–	3983
2023 Q1	$48.1K	Buy	+45,349	New	+$65.4K	﹤0.01%	3873
2020 Q1	–	Sell	-126,052	Closed	-$691K	–	3711
2019 Q4	$691K	Buy	+126,052	New	+$709K	﹤0.01%	3222
2018 Q2	–	Sell	-41,519	Closed	-$637K	–	3678
2018 Q1	$637K	Buy	+41,519	New	+$594K	﹤0.01%	3143
2016 Q2	–	Sell	-10,173	Closed	-$342K	–	3831
2016 Q1	$342K	Buy	+10,173	New	+$320K	﹤0.01%	3310
2015 Q3	–	Sell	-10,267	Closed	-$496K	–	3912
2015 Q2	$496K	Buy	+10,267	New	+$433K	﹤0.01%	3449
2014 Q4	–	Sell	-382	Closed	-$7K	–	4207
2014 Q3	$7K	Buy	382 +309	+423%	+$6.31K	﹤0.01%	5004
2014 Q2	$2K	Buy	+73	New	+$1.48K	﹤0.01%	5220

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's PGEN Position: Q2 2023 in Review

Ameriprise sold out of Precigen (PGEN) in Q2 2023, closing a stake of 45,349 shares — an estimated $48.1K sold.

Ameriprise first reported a position in PGEN in Q2 2014 and held it in 7 quarters. The position peaked at $691K in Q4 2019. 138 funds tracked by Wall St. Rank hold PGEN as of Q2 2023.

Ameriprise reported no remaining Precigen position as of Q2 2023 after selling out during the quarter.
Ameriprise sold 45,349 Precigen shares in Q2 2023, an estimated $48.1K.
Ameriprise first reported a position in Precigen in Q2 2014 and held it in 7 quarters.
Ameriprise's Precigen position peaked at $691K in Q4 2019.
138 funds tracked by Wall St. Rank held Precigen as of Q2 2023.

Based on Ameriprise's 13F filing for Q2 2023, filed 14 Aug 2023.